VR Adviser, LLC Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$1.5T
Holdings
37
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (37 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | APGEAPOGEE THERAPEUTICS INC | 8,493,321 | $384.7B | 26.40% | |
| 2 | OCULOCULAR THERAPEUTIX INC | 12,762,462 | $109.0B | 7.48% | |
| 3 | ELVNENLIVEN THERAPEUTICS INC | 4,026,331 | $90.6B | 6.22% | |
| 4 | PRAXPRAXIS PRECISION MEDICINES I | 989,985 | $76.2B | 5.23% | |
| 5 | VRDNVIRIDIAN THERAPEUTICS INC | 3,882,709 | $74.4B | 5.11% | |
| 6 | ORKAORUKA THERAPEUTICS INC | 3,285,620 | $63.7B | 4.37% | |
| 7 | SYRESPYRE THERAPEUTICS INC | 2,685,448 | $62.5B | 4.29% | |
| 8 | PHVSPHARVARIS N V | 3,220,130 | $61.7B | 4.24% | |
| 9 | KALVKALVISTA PHARMACEUTICALS INC | 6,249,731 | $52.9B | 3.63% | |
| 10 | DYNDYNE THERAPEUTICS INC | 2,173,913 | $51.2B | 3.51% | |
| 11 | COGTCOGENT BIOSCIENCES INC | 5,684,411 | $44.3B | 3.04% | |
| 12 | ERASERASCA INC | 16,216,216 | $40.7B | 2.79% | |
| 13 | DNTHDIANTHUS THERAPEUTICS INC | 1,744,373 | $38.0B | 2.61% | |
| 14 | UPBUPSTREAM BIO INC | 2,295,319 | $37.7B | 2.59% | |
| 15 | ORICORIC PHARMACEUTICALS INC | 4,394,527 | $35.5B | 2.43% | |
| 16 | ENGNENGENE HOLDINGS INC | 5,046,414 | $33.6B | 2.30% | |
| 17 | MRUSMERUS N V | 592,411 | $24.9B | 1.71% | |
| 18 | CATBUSDASTRIA THERAPEUTICS INC | 2,457,348 | $22.0B | 1.51% | |
| 19 | CDTXCIDARA THERAPEUTICS INC | 765,723 | $20.6B | 1.41% | |
| 20 | CGEMCULLINAN THERAPEUTICS INC | 1,379,965 | $16.8B | 1.15% | |
| 21 | FDMT4D MOLECULAR THERAPEUTICS IN | 2,952,371 | $16.4B | 1.13% | |
| 22 | ARTVARTIVA BIOTHERAPEUTICS INC | 1,609,569 | $16.2B | 1.11% | |
| 23 | —MERSANA THERAPEUTICS INC | 10,257,790 | $14.7B | 1.01% | |
| 24 | ABVXABIVAX SA | 1,345,780 | $9.9B | 0.68% | |
| 25 | AQSTAQUESTIVE THERAPEUTICS INC | 2,629,786 | $9.4B | 0.64% | |
| 26 | APLTAPPLIED THERAPEUTICS INC | 9,990,591 | $8.6B | 0.59% | |
| 27 | —PERCEPTIVE CAP SOLUTIONS COR | 750,000 | $7.6B | 0.52% | |
| 28 | TERNTERNS PHARMACEUTICALS INC | 1,077,090 | $6.0B | 0.41% | |
| 29 | TSHATAYSHA GENE THERAPIES INC | 3,225,180 | $5.6B | 0.38% | |
| 30 | TRVITREVI THERAPEUTICS INC | 1,266,457 | $5.2B | 0.36% | |
| 31 | ZURAZURA BIO LTD | 2,023,166 | $5.1B | 0.35% | |
| 32 | IPSCCENTURY THERAPEUTICS INC | 3,957,186 | $4.0B | 0.27% | |
| 33 | —CASI PHARMACEUTICALS INC | 987,259 | $2.8B | 0.19% | |
| 34 | TNYATENAYA THERAPEUTICS INC | 1,555,556 | $2.2B | 0.15% | |
| 35 | TENXTENAX THERAPEUTICS INC | 208,333 | $1.3B | 0.09% | |
| 36 | GLYCEURGLYCOMIMETICS INC | 3,000,000 | $747.0M | 0.05% | |
| 37 | TILINSTIL BIO INC | 33,177 | $633.3M | 0.04% |